More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...
Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly. Most people with liver disease are symptom-free until complications like ...
A blood test looking for five specific proteins can predict metabolic dysfunction-associated steatotic liver disease, more commonly known as fatty liver disease, researchers are scheduled to report at ...
A new blood test may help detect liver cancer earlier in people with chronic liver disease, potentially improving access to ...
Assessing the toxicity of food contaminants—including carcinogenic potential—is a major challenge in evaluating the risks ...
Austin, Texas, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Human Liver Model Market Size & Growth Analysis: As per SNS Insider, the Human Liver Model Market was valued at USD 1.21 billion in 2025 and is ...
A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...
A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver ...
A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results